Results 341 to 350 of about 2,377,300 (402)
Some of the next articles are maybe not open access.
American Journal of Kidney Diseases, 2019
RATIONALE & OBJECTIVE On account of the high prevalence of cardiovascular disease in patients with kidney failure, clinical practice guidelines recommend regular screening for asymptomatic coronary artery disease (CAD) in patients on the kidney ...
Tracey Ying +6 more
semanticscholar +1 more source
RATIONALE & OBJECTIVE On account of the high prevalence of cardiovascular disease in patients with kidney failure, clinical practice guidelines recommend regular screening for asymptomatic coronary artery disease (CAD) in patients on the kidney ...
Tracey Ying +6 more
semanticscholar +1 more source
Patient preferences and cost–utility analysis
Applied Nursing Research, 2005This column discusses patient preference measures and their application in cost utility analysis. A variety of methods of eliciting patient preferences by use of generic utility measures are described. Practical issues in the use of utility measures are discussed.
Patricia W. Stone, Christine Elnitsky
openaire +3 more sources
Cost‐utility analysis of the National Health Screening Program for chronic kidney disease in Korea
Nephrology, 2018Although a National Health Screening Program (NHSP) for chronic kidney disease (CKD) has been implemented in Korea since 2002, its cost‐effectiveness has never been determined. This study aimed to estimate the cost‐utility of NHSP for CKD in Korea.
D. Go +5 more
semanticscholar +1 more source
Cost-utility Analysis for Recurrent Lumbar Disc Herniation
Clinical Spine Surgery, 2019Supplemental Digital Content is available in the text. Study Design: This study was an ambispective long-term cost-utility analysis with retrospective chart review and included the prospective completion of health questionnaires by patients.
Carmen Selva-Sevilla +2 more
semanticscholar +1 more source
Cost-utility analysis of taxane therapy
American Journal of Health-System Pharmacy, 1997A cost-utility analysis of docetaxel versus paclitaxel in patients with anthracycline-resistant metastatic breast cancer was reviewed. Cost-utility analysis provides estimates of the additional cost of a new therapy per quality-adjusted life-year (QALY) saved or gained.
openaire +3 more sources
Cost-utility analysis of home parenteral nutrition
British Journal of Surgery, 1996An economic evaluation of home parenteral nutrition (HPN) for intestinal failure is presented. The cost-utility of HPN and factors affecting the cost-utility ratio were examined to determine whether current practice is the most efficient way of treating intestinal failure.
Miles Irving, D. M. Richards
openaire +3 more sources
A Cost-Utility Analysis of Neonatal Circumcision
Medical Decision Making, 2004A cost-utility analysis, based on published data from multiple observational studies, comparing boys circumcised at birth and those not circumcised was undertaken using the Quality of Well-being Scale, a Markov analysis, the standard reference case, and a societal perspective.
openaire +3 more sources
2017
Cost-utility analysis (CUA) has become widely used, particularly in the United Kingdom, compared with other techniques within cost-effectiveness analysis. CUA uses metrics such as the quality-adjusted life year (QALY) to assess the effectiveness of an intervention compared with an alternative. The QALY accounts for mortality (life years) and morbidity (
openaire +2 more sources
Cost-utility analysis (CUA) has become widely used, particularly in the United Kingdom, compared with other techniques within cost-effectiveness analysis. CUA uses metrics such as the quality-adjusted life year (QALY) to assess the effectiveness of an intervention compared with an alternative. The QALY accounts for mortality (life years) and morbidity (
openaire +2 more sources
An Instrumentalist Critique of “Cost-Utility Analysis”
Journal of Economic Issues, 1995(1995). An Instrumentalist Critique of “Cost-Utility Analysis”. Journal of Economic Issues: Vol. 29, No. 4, pp. 1083-1096.
William Hildred, Fred Beauvais
openaire +2 more sources
Cost–utility analysis in evaluating prophylaxis in haemophilia
Haemophilia, 2004Summary. Prophylaxis is an expensive form of management in haemophilia but has demonstrated many advantages with respect to decreasing joint bleeds and potentially preventing joint damage. The valuation of prophylaxis and how the costs and benefits of this intervention compare with other interventions in the management of haemophiliacs can be ...
W. J. Ungar, Brian M. Feldman, M. Carcao
openaire +3 more sources